"As a result of the foregoing, the Company’s net sales from continuing operations for the year ended February 3, 2018 will be reclassified to $1,395.8 million and its net loss from continuing operations for the year ended February 3, 2018 will be reclassified to $144.5 million, among other items. After giving effect to the reclassification of the Retail Rx Disc Ops Business for the year ended February 3, 2018, it is not anticipated that there will be a significant change in the Company’s results of operations for the fiscal year ended February 2, 2019, as compared to the results of operations with respect to continuing operations for the fiscal year ended February 3, 2018. "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.